Publication: Human single chain monoclonal antibody that recognizes matrix protein of heterologous influenza A virus subtypes
Issued Date
2009-07-01
Resource Type
ISSN
01660934
Other identifier(s)
2-s2.0-67349114873
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Virological Methods. Vol.159, No.1 (2009), 105-111
Suggested Citation
Ornnuthchar Poungpair, Wanpen Chaicumpa, Kasem Kulkeaw, Santi Maneewatch, Kanyarat Thueng-in, Potjanee Srimanote, Pongsri Tongtawe, Thaweesak Songserm, Porntippa Lekcharoensuk, Pramuan Tapchaisri Human single chain monoclonal antibody that recognizes matrix protein of heterologous influenza A virus subtypes. Journal of Virological Methods. Vol.159, No.1 (2009), 105-111. doi:10.1016/j.jviromet.2009.03.010 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/27691
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Human single chain monoclonal antibody that recognizes matrix protein of heterologous influenza A virus subtypes
Other Contributor(s)
Abstract
Matrix protein (M1) is predominant and has pivotal role in the influenza A virus replication and assembly. It is therefore an attractive target for antiviral drugs, siRNA studies, and therapeutic antibodies. Nevertheless, therapeutic antibody that interferes with the M1 multiplex function has never been developed. In this study, human single monoclonal antibody fragments (HuScFvs) to M1 were generated. Full length recombinant M1 (rM1) was produced from cDNA prepared from genome of highly pathogenic avian influenza virus, A/H5N1. The rM1 was used as an antigen in phage bio-panning to select phage clones displaying HuScFv from a human antibody phage display library. Several phage clones displaying HuScFv bound to the rM1 and harboring the respective huscfv gene inserts were isolated. RFLP experiments revealed multiple DNA banding patterns which indicated epitope/affinity diversity of the HuScFv. The HuScFv were tested for their binding to native M1 of homologous and heterologous influenza A viruses using ELISA as well as incorporating immunostaining and immunofluorescence studies with infected MDCK cells. One such protein produced from a selected phage clone blocked binding of M1 to viral RNA. The HuScFv in their in vivo functional format, e.g. cell-penetrating molecules, should be developed and tested as a broad spectrum anti-A/influenza. © 2009 Elsevier B.V. All rights reserved.